HomeStock ScreenerRama PhosphatesIntrinsic Value

Rama Phosphates Intrinsic Value

Rama Phosphates (RAMAPHO) median intrinsic value is ₹235.00 from 10 valuation models (range ₹36–₹284), vs current price ₹120.87 — +94.4% upside (Trading Below Calculated Value), margin of safety 48.6%. For current market price and key ratios, visit RAMAPHO screener.

Market Price (CMP)
₹120.87
Primary Intrinsic Value
₹182.40
Market Cap
₹217.6 Cr
+94.4% Upside
Median Value
₹235.00
Value Range
₹36 - ₹284
Assessment
Trading Below Calculated Value
Safety Margin
48.6%

RAMAPHO Valuation Methods Summary — DCF, Graham Number & P/E

Rama Phosphates intrinsic value across 10 models vs current price ₹120.87 — upside/downside and value range per method. Check RAMAPHO market capitalization to track the company's total market size over time.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹182.40 ₹145.92 - ₹218.88 +50.9% EPS: ₹15.20, Sector P/E: 12x
Book Value Method asset ₹235.00 ₹211.50 - ₹258.50 +94.4% Book Value/Share: ₹235.00, P/B: 1.0x
Revenue Multiple Method revenue ₹241.74 ₹217.57 - ₹265.91 +100.0% Revenue/Share: ₹516.11, P/S: 0.8x
EBITDA Multiple Method earnings ₹241.74 ₹217.57 - ₹265.91 +100.0% EBITDA: ₹90.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹103.15 ₹82.52 - ₹123.78 -14.7% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹97.28 ₹87.55 - ₹107.01 -19.5% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹122.50 ₹110.25 - ₹134.75 +1.3% Revenue Growth: 1.5%, Adj P/E: 8.1x
ROE Based Valuation profitability ₹241.74 ₹217.57 - ₹265.91 +100.0% ROE: 12.8%, P/E Multiple: 12x
Graham Defensive Method conservative ₹283.50 ₹255.15 - ₹311.85 +134.5% EPS: ₹15.20, BVPS: ₹235.00
Dividend Yield Method dividend ₹36.26 ₹32.63 - ₹39.89 -70.0% DPS: ₹0.25, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

RAMAPHO Intrinsic Value vs Market Price — All Valuation Models

Rama Phosphates fair value range ₹36–₹284 vs current market price ₹120.87 across 10 valuation models. See Rama Phosphates P/B ratio trends to compare market price against book value per share.

RAMAPHO Intrinsic Value Analysis — Undervalued or Overvalued?

Rama Phosphates median intrinsic value ₹235.00, current price ₹120.87 — Trading Below Calculated Value by 94.4%, margin of safety 48.6%.

What is the intrinsic value of RAMAPHO?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Rama Phosphates (RAMAPHO) is ₹235.00 (median value). With the current market price of ₹120.87, this represents a +94.4% variance from our estimated fair value.

The valuation range spans from ₹36.26 to ₹283.50, indicating ₹36.26 - ₹283.50.

Is RAMAPHO undervalued or overvalued?

Based on our multi-method analysis, Rama Phosphates (RAMAPHO) appears to be trading below calculated value by approximately 94.4%.

RAMAPHO Financial Health — Key Ratios vs Industry Benchmarks

Rama Phosphates financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 23.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 12.8% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 10.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.29x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

RAMAPHO Cash Flow Quality — Operating & Free Cash Flow

Rama Phosphates operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹20 Cr ₹9 Cr Positive Free Cash Flow 7/10
March 2025 ₹40 Cr ₹38 Cr Positive Free Cash Flow 8/10
March 2024 ₹-5 Cr ₹-11 Cr Negative Cash Flow 3/10
March 2023 ₹-36 Cr ₹-40 Cr Negative Cash Flow 3/10
March 2022 ₹-9 Cr ₹-25 Cr Negative Cash Flow 3/10